Clin2
NCT06622824Possibly a fitNot yet recruiting

Study of a new scalp solution for male hair loss

Androgenetic Alopecia (AGA)

Part of Skin clinical trials.

This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
756 people
Ages
18 years to 49 years
Study type
Interventional

Who can take part

  • Be a male aged 18 to 49 years
  • Have a diagnosis of male pattern baldness (androgenetic alopecia)
  • Have a specific pattern of hair loss (Norwood-Hamilton types IIIv, IV, or V)
  • Agree to keep the same hairstyle, length, and color during the study
  • Be willing to use effective birth control during the study and for 3 months after
  • Not have used certain hair loss treatments like finasteride or minoxidil recently

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07327359Recruiting· Phase 1/Phase 2
Hair loss treatment for men with male pattern baldness

This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.

Botany, New South Wales
NCT07529977Not yet recruiting· Phase 3
Oral minoxidil pill for male hair loss

This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.

NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness

This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.

Xinxiang, Henan
NCT07317544Recruiting· Phase 1/Phase 2
ABS-201 trial for hair loss in healthy adults

This trial tests a new medicine (ABS-201) in healthy people to see if it is safe and works for hair loss. It involves multiple doses and compares results based on whether you have the common type of hair loss called androgenetic alopecia.

Sydney, New South Wales
NCT07018349Not yet recruiting
Low-dose oral minoxidil for pattern hair loss

This trial tests a low-dose oral form of minoxidil (a hair growth medicine) for people with pattern hair loss. It aims to see if this treatment helps regrow hair in a convenient way.

Karachi, Sindh
NCT07758400Not yet recruiting
Microneedling for male pattern hair loss

This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.

Beijing, Beijing Municipality

Hear when a new Androgenetic Alopecia (AGA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.